FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for octreotide acetate (ANDA) by Hikma Pharmaceuticals USA Inc. The approval updates the labeling or scope of use for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Gastroenteropancreatic Neuroendocrine Tumor
• Vipoma

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)